Aging
Navigate
Submit an Article
Research Paper|Volume 12, Issue 20|pp. 20835–20861
SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
Back to articleFigure 5(5 of 9)
100%
Figure 5
Figure 5.Gene-Pathway interaction network of SMARCD3, CRIP2, PRAM1, HSPB2 and CERCAM in colorectal cancer.